RespireRx Pharmaceuticals Inc. (RSPI)
USD 0.0
(-23.81%)
USD 0.0
(-23.81%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | 5167.00 |
| Gross Profit | - | - | - | - | - | -5167.00 |
| Operating Expenses | 1.57 Million | 2.55 Million | 3.31 Million | 1.73 Million | 2.17 Million | 4.24 Million |
| Selling, General and Administrative Expenses | 1.14 Million | 1.85 Million | 2.67 Million | 1.13 Million | 1.48 Million | 2.51 Million |
| Research and Development Expenses | 429.53 Thousand | 702.04 Thousand | 638.27 Thousand | 599.32 Thousand | 688.28 Thousand | 1.73 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.57 Million | 2.55 Million | 3.31 Million | 1.73 Million | 2.17 Million | 4.24 Million |
| Operating Income | -1.57 Million | -2.55 Million | -3.31 Million | -1.73 Million | -2.17 Million | -4.24 Million |
| Interest Expense | 603.81 Thousand | 724.76 Thousand | 545.67 Thousand | 404.66 Thousand | 136.24 Thousand | 102.22 Thousand |
| Income Tax Expense | -80.45 Thousand | 724.76 Thousand | 545.67 Thousand | 404.66 Thousand | 279.02 Thousand | 44.07 Thousand |
| Earnings before Tax | -2.1 Million | -3.14 Million | -4.3 Million | -2.11 Million | -2.59 Million | -4.29 Million |
| Net Income | -3.97 Million | -3.86 Million | -4.84 Million | -2.51 Million | -2.59 Million | -4.29 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.19 | -6.45 | -7.73 | -17.75 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.19 | -6.45 | -7.73 | -17.75 |
| Weighted Average Shares Outstanding | 111.32 Million | 88.34 Million | 25.85 Million | 390.84 Thousand | 335.11 Thousand | 241.82 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 111.32 Million | 88.34 Million | 25.85 Million | 390.84 Thousand | 335.11 Thousand | 241.82 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -1.49 Million | -963.75 Thousand | -2.42 Million | -378.52 Thousand | -2.45 Million | -4.24 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 332.5 Thousand | 465.85 Thousand | 390.37 Thousand | 1.57 Million | 220.96 Thousand | 388.96 Thousand |
| Selling, General and Administrative Expenses | 245.12 Thousand | 367.64 Thousand | 291.94 Thousand | - | 191.73 Thousand | 250.91 Thousand |
| Research and Development Expenses | 87.38 Thousand | 98.21 Thousand | 98.42 Thousand | - | 29.22 Thousand | 138.05 Thousand |
| Other Expenses | - | - | - | -71.16 Thousand | - | - |
| Cost and Expenses | 332.5 Thousand | 465.85 Thousand | 390.37 Thousand | 1.57 Million | 220.96 Thousand | 388.96 Thousand |
| Operating Income | -332.5 Thousand | -465.85 Thousand | -390.37 Thousand | -1.57 Million | -220.96 Thousand | -388.96 Thousand |
| Interest Expense | -73.4 Thousand | 225.04 Thousand | 67.27 Thousand | 603.81 Thousand | 70 Thousand | 94.64 Thousand |
| Income Tax Expense | -332.51 | 224.58 Thousand | 106.96 Thousand | -80.45 Thousand | 27.46 Thousand | -11.03 Thousand |
| Earnings before Tax | -409.16 Thousand | -681.03 Thousand | -430.06 Thousand | -2.1 Million | -289.69 Thousand | -472.57 Thousand |
| Net Income | -409.16 Thousand | -681.03 Thousand | -537.02 Thousand | -2.02 Million | -317.15 Thousand | -461.54 Thousand |
| Earnings Per Share Basic | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.00 | -0.00 | -0.00 | - | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 267.73 Million | 168.21 Million | 137.18 Million | 111.32 Million | 125.54 Million | 119.26 Million |
| Weighted Average Shares Outstanding (Diluted) | 267.73 Million | 168.21 Million | 137.18 Million | 111.32 Million | 125.54 Million | 119.26 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -332.5 Thousand | -465.85 Thousand | -390.37 Thousand | - | -292.12 Thousand | -388.96 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
300452
ISLAX
SEAC
CAPTW
GNYPF
MBHCF